Company intelligence / Profile preview

Lorca Laboratory

Waltham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Lorca Lab is a stealth-stage biotechnology company focused on developing novel therapeutics that target RNA-binding proteins to treat complex diseases. Founded by Nobel laureate Michael Rosbash, the company leverages deep expertise in RNA biology and circadian rhythms to identify new regulatory mechanisms in gene expression. Their platform aims to modulate RNA processing and stability, offering a unique approach to addressing unmet needs in neurodegeneration and cancer. Lorca Lab operates primarily in the discovery and pre-clinical stages, utilizing advanced screening and computational tools to build its pipeline.

Therapeutic areas: NeurologyOncology
Modalities: Small moleculeRNA therapy
Industry: Biotech

Beyond the preview

Go deeper on Lorca Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lorca Laboratory.

Explore the full profile